Premature aging/senescence in cancer cells facing therapy: good or bad?
暂无分享,去创建一个
Aurélie Martinez | F. Rodier | Francis Rodier | Llilians Calvo Gonzalez | Sabrina Ghadaouia | Aurélie Martinez | Sabrina Ghadaouia
[1] I. Roninson,et al. Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity. , 2004, Cancer research.
[2] L. Hayflick,et al. The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.
[3] D. Schadendorf,et al. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. , 1993, Journal of immunology.
[4] D. Walker,et al. Evidence that aging and amyloid promote microglial cell senescence. , 2007, Rejuvenation research.
[5] R. Derynck,et al. Effects of MGSA/GRO alpha on melanocyte transformation. , 1991, Oncogene.
[6] J. Gil,et al. Induced pluripotent stem cells and senescence: learning the biology to improve the technology , 2010, EMBO reports.
[7] Soyoung Lee,et al. A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy , 2002, Cell.
[8] G. Castellani,et al. Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans , 2007, Mechanisms of Ageing and Development.
[9] G. Bratthauer,et al. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. , 2000, Cancer research.
[10] A. Newton,et al. Protein Kinase C: Structure, Function, and Regulation (*) , 1995, The Journal of Biological Chemistry.
[11] L. Hartmann,et al. Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. , 2010, Cancer research.
[12] J. Griffith,et al. Mammalian Telomeres End in a Large Duplex Loop , 1999, Cell.
[13] M. Hayat. Tumor Dormancy, Quiescence, and Senescence, Volume 1 , 2013, Tumor Dormancy and Cellular Quiescence and Senescence.
[14] R. Reddel,et al. The first molecular details of ALT in human tumor cells. , 2005, Human molecular genetics.
[15] A M Olovnikov,et al. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. , 1973, Journal of theoretical biology.
[16] R. Weinberg,et al. The signals and pathways activating cellular senescence. , 2005, The international journal of biochemistry & cell biology.
[17] J. Campisi,et al. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation , 2004, Journal of Cell Science.
[18] Jun Chen,et al. Contribution of p16INK4a and p21CIP1 pathways to induction of premature senescence of human endothelial cells: permissive role of p53. , 2006, American journal of physiology. Heart and circulatory physiology.
[19] K. Mohammad,et al. Modulation of mammalian life span by the short isoform of p53. , 2004, Genes & development.
[20] H. Saya,et al. Real-time in vivo imaging of p16Ink4a reveals cross talk with p53 , 2009, The Journal of cell biology.
[21] J. Grichnik,et al. Nevus Senescence , 2011, ISRN dermatology.
[22] N. Carter,et al. A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.
[23] Jianmin Zhang,et al. p16INK4a modulates p53 in primary human mammary epithelial cells. , 2006, Cancer research.
[24] A. Brenner,et al. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation , 1998, Oncogene.
[25] L. Elmore,et al. p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells , 2005, International journal of radiation biology.
[26] B. Ames,et al. Oxidative DNA damage and senescence of human diploid fibroblast cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Campisi,et al. Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo , 2009, Nature Protocols.
[28] T. Tsuji,et al. Alveolar cell senescence in patients with pulmonary emphysema. , 2006, American journal of respiratory and critical care medicine.
[29] N. LeBrasseur,et al. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs , 2015, Aging cell.
[30] S. Anton,et al. Molecular inflammation: Underpinnings of aging and age-related diseases , 2009, Ageing Research Reviews.
[31] Soyoung Lee,et al. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy , 2013, Nature.
[32] F. Rodier,et al. DDR-mediated crosstalk between DNA-damaged cells and their microenvironment , 2015, Front. Genet..
[33] A. Senderowicz,et al. S-Phase-specific activation of PKC alpha induces senescence in non-small cell lung cancer cells. , 2008, The Journal of biological chemistry.
[34] M. Manns,et al. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis , 2002 .
[35] R. Pignolo,et al. Replicative senescence of human fibroblast-like cells in culture. , 1993, Physiological reviews.
[36] J. Campisi,et al. Caspase‐independent cytochrome c release is a sensitive measure of low‐level apoptosis in cell culture models , 2005, Aging cell.
[37] R. DePinho,et al. Telomeres, stem cells, senescence, and cancer. , 2004, The Journal of clinical investigation.
[38] Weijun Su,et al. Induction of p38δ Expression Plays an Essential Role in Oncogenic ras-Induced Senescence , 2013, Molecular and Cellular Biology.
[39] Rugang Zhang,et al. Detection of senescence-associated heterochromatin foci (SAHF). , 2013, Methods in molecular biology.
[40] D. DiMaio,et al. Senescence‐associated β‐galactosidase is lysosomal β‐galactosidase , 2006 .
[41] D. DiMaio,et al. Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. , 2006, Aging cell.
[42] Manuel Serrano,et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity , 2009, Nature.
[43] Anil Wipat,et al. Feedback between p21 and reactive oxygen production is necessary for cell senescence , 2010, Molecular systems biology.
[44] J. Campisi,et al. DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion , 2011, Journal of Cell Science.
[45] S. Lowe,et al. Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence , 2003, Cell.
[46] Le Xu,et al. Sunitinib induces cellular senescence via p53/Dec1 activation in renal cell carcinoma cells , 2013, Cancer science.
[47] K. Schulze-Osthoff,et al. Enhanced killing of therapy‐induced senescent tumor cells by oncolytic measles vaccine viruses , 2014, International journal of cancer.
[48] Michael R. Green,et al. Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7 , 2008, Cell.
[49] M. Tainsky,et al. Epigenetic Silencing of IRF7 and/or IRF5 in Lung Cancer Cells Leads to Increased Sensitivity to Oncolytic Viruses , 2011, PloS one.
[50] D. DiMaio,et al. Rapid induction of senescence in human cervical carcinoma cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[51] T. de Lange,et al. Shelterin: the protein complex that shapes and safeguards human telomeres. , 2005, Genes & development.
[52] A. Senderowicz,et al. S-Phase-specific Activation of PKCα Induces Senescence in Non-small Cell Lung Cancer Cells* , 2008, Journal of Biological Chemistry.
[53] Satoshi Matsumoto,et al. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas , 2002, Nature Genetics.
[54] N. LeBrasseur,et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders , 2011, Nature.
[55] Jonathan Melamed,et al. Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence , 2008, Cell.
[56] Judith Campisi,et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B , 2012, Nature Medicine.
[57] J. Shay,et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.
[58] F. D. D. Fagagna,et al. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation , 2012, Nature Cell Biology.
[59] Rameen Beroukhim,et al. Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.
[60] E. Kandel,et al. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. , 1999, Cancer research.
[61] James H. Doroshow,et al. Translational research in oncology—10 years of progress and future prospects , 2014, Nature Reviews Clinical Oncology.
[62] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[63] Sung Young Kim,et al. Chronic treatment with ginsenoside Rg3 induces Akt-dependent senescence in human glioma cells. , 2012, International journal of oncology.
[64] J. Gil,et al. Senescence: a new weapon for cancer therapy. , 2012, Trends in cell biology.
[65] T. Luedde,et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development , 2011, Nature.
[66] A. El‐Naggar,et al. p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. , 2012, Cancer cell.
[67] S. Lowe,et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. , 1998, Genes & development.
[68] L. Elmore,et al. Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction* , 2002, The Journal of Biological Chemistry.
[69] P. Muti,et al. SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells , 2012, Oncogene.
[70] David F Jarrard,et al. Therapy-induced senescence in cancer. , 2010, Journal of the National Cancer Institute.
[71] S. Melov,et al. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts , 2003, Nature Cell Biology.
[72] P. Nelson,et al. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. , 2006, Cancer research.
[73] R. Poon,et al. p53 deficiency enhances mitotic arrest and slippage induced by pharmacological inhibition of Aurora kinases , 2014, Oncogene.
[74] Aaron Bensimon,et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication , 2006, Nature.
[75] J. Sharpe,et al. Senescence Is a Developmental Mechanism that Contributes to Embryonic Growth and Patterning , 2013, Cell.
[76] Carol W. Greider,et al. Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.
[77] R. Reddel,et al. Telomere dynamics and telomerase activity in in vitro immortalised human cells. , 1997, European journal of cancer.
[78] K. Lim,et al. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. , 2007, Genes & development.
[79] S. Lowe,et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas , 2011, Nature.
[80] J. D. Benson,et al. Papillomavirus E2 induces senescence in HPV‐positive cells via pRB‐ and p21CIP‐dependent pathways , 2000, The EMBO journal.
[81] N. Isakov,et al. PKCη promotes senescence induced by oxidative stress and chemotherapy , 2014, Cell Death and Disease.
[82] S. Lowe,et al. Senescence of Activated Stellate Cells Limits Liver Fibrosis , 2008, Cell.
[83] J. Campisi,et al. Secretion of Vascular Endothelial Growth Factor by Primary Human Fibroblasts at Senescence* , 2006, Journal of Biological Chemistry.
[84] G. Mills,et al. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis , 2006, Proceedings of the National Academy of Sciences.
[85] Y. Ouchi,et al. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras–MAPK signaling in human cancer cells , 2006, Oncogene.
[86] C. Harley,et al. Telomeres shorten during ageing of human fibroblasts , 1990, Nature.
[87] J. Campisi,et al. The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.
[88] Melissa St-Pierre,et al. Aging increases p16 INK4a expression in vascular smooth-muscle cells. , 2009, Bioscience reports.
[89] D. Brenner,et al. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype , 2003, Hepatology.
[90] Luke A. Gilbert,et al. DNA Damage-Mediated Induction of a Chemoresistant Niche , 2010, Cell.
[91] P. Hornsby,et al. Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. , 2007, Cancer research.
[92] M. Barbacid,et al. Tumour biology: Senescence in premalignant tumours , 2005, Nature.
[93] J. Campisi,et al. Epithelial-Mesenchymal Transition Induced by Senescent Fibroblasts , 2012, Cancer Microenvironment.
[94] Baojie Li,et al. p53 Deficiency Leads to Compensatory Up-Regulation of p16INK4a , 2009, Molecular Cancer Research.
[95] J. Ewald,et al. Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancer. , 2012, Translational oncology.
[96] K. Vousden,et al. p53 mutations in cancer , 2013, Nature Cell Biology.
[97] T. Brümmendorf,et al. Pluripotent stem cells escape from senescence-associated DNA methylation changes , 2013, Genome Research.
[98] J. Campisi,et al. Cellular senescence: when bad things happen to good cells , 2007, Nature Reviews Molecular Cell Biology.
[99] D. Kurz,et al. Cellular Senescence After Single and Repeated Balloon Catheter Denudations of Rabbit Carotid Arteries , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[100] J. Campisi,et al. Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion , 2009, Nature Cell Biology.
[101] Stephen N. Jones,et al. p53 mutant mice that display early ageing-associated phenotypes , 2002, Nature.
[102] R. Bernards,et al. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence , 2006, Nature Cell Biology.
[103] D. Kurz,et al. Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. , 2000, Journal of cell science.
[104] H. Stein,et al. Oncogene-induced senescence as an initial barrier in lymphoma development , 2005, Nature.
[105] Dimitris Kletsas,et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints , 2006, Nature.
[106] J. Mestan,et al. Skp2 is oncogenic and overexpressed in human cancers , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[107] H. Dvorak,et al. Differential expression of thymosin β‐10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[108] Xiaowo Wang,et al. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. , 2011, Genes & development.
[109] J. Campisi,et al. Tumor Suppressor and Aging Biomarker p16INK4a Induces Cellular Senescence without the Associated Inflammatory Secretory Phenotype* , 2011, The Journal of Biological Chemistry.
[110] F. Zindy,et al. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging , 1997, Oncogene.
[111] Jing Wang,et al. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence , 2010, Nature.
[112] G. Wahl,et al. Linking the p53 tumor suppressor pathway to somatic cell reprogramming , 2009, Nature.
[113] G. Wahl,et al. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. , 1994, Genes & development.
[114] M. Roizen,et al. Hallmarks of Cancer: The Next Generation , 2012 .
[115] N. Dyson,et al. pRB plays an essential role in cell cycle arrest induced by DNA damage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[116] M. Blasco,et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming , 2009, Nature.
[117] D. Peeper,et al. Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network , 2008, Cell.
[118] Xinbin Chen,et al. DEC1, a Basic Helix-Loop-Helix Transcription Factor and a Novel Target Gene of the p53 Family, Mediates p53-dependent Premature Senescence* , 2008, Journal of Biological Chemistry.
[119] D. Louis,et al. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. , 1999, The American journal of pathology.
[120] Jason A. Koutcher,et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.
[121] J. Campisi,et al. Four faces of cellular senescence , 2011, The Journal of cell biology.
[122] J. Campisi,et al. Mitochondrial DNA damage induces apoptosis in senescent cells , 2013, Cell Death and Disease.
[123] Hua Yu,et al. Sunitinib Induces Apoptosis and Growth Arrest of Medulloblastoma Tumor Cells by Inhibiting STAT3 and AKT Signaling Pathways , 2010, Molecular Cancer Research.
[124] K. Kinzler,et al. The multistep nature of cancer. , 1993, Trends in genetics : TIG.
[125] F. Rodier,et al. Manipulating senescence in health and disease: emerging tools , 2015, Cell cycle.
[126] B. Ames,et al. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[127] S. Donell,et al. The role of chondrocyte senescence in osteoarthritis , 2002, Aging cell.
[128] W. Hahn,et al. Mitogen Stimulation Cooperates with Telomere Shortening To Activate DNA Damage Responses and Senescence Signaling , 2004, Molecular and Cellular Biology.
[129] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[130] R. Splittgerber,et al. Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescence , 2012, EMBO molecular medicine.
[131] E. Flores,et al. Rescue of key features of the p63‐null epithelial phenotype by inactivation of Ink4a and Arf , 2009, The EMBO journal.
[132] Judith Campisi,et al. Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.
[133] R. Randall,et al. Doxorubicin induces cell senescence preferentially over apoptosis in the FU‐SY‐1 synovial sarcoma cell line , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[134] Robert A. Weinberg,et al. Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type , 2006, Cell cycle.
[135] Y. Liu,et al. Dexamethasone Reduces Sensitivity to Cisplatin by Blunting p53-Dependent Cellular Senescence in Non-Small Cell Lung Cancer , 2012, PloS one.
[136] C. Pereira,et al. Senescence impairs successful reprogramming to pluripotent stem cells. , 2009, Genes & development.
[137] S. Schwarze,et al. The identification of senescence-specific genes during the induction of senescence in prostate cancer cells. , 2005, Neoplasia.
[138] S. Joel,et al. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. , 2002, Cancer research.
[139] Jun Yao,et al. Distinct epigenetic changes in the stromal cells of breast cancers , 2005, Nature Genetics.
[140] D. Drummond-Barbosa. Stem Cells, Their Niches and the Systemic Environment: An Aging Network , 2008, Genetics.
[141] Bernadett Papp,et al. Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape , 2011, Cell Research.
[142] D. Bar-Sagi,et al. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. , 2004, Cancer cell.
[143] B. Chabner,et al. Chemotherapy and the war on cancer , 2005, Nature Reviews Cancer.
[144] A. Azmi,et al. Therapeutic targeting of replicative immortality , 2015, Seminars in cancer biology.
[145] L. Zender,et al. Immune surveillance of senescent cells--biological significance in cancer- and non-cancer pathologies. , 2012, Carcinogenesis.
[146] J. Hoeijmakers,et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. , 2014, Developmental cell.
[147] A. L. Fridman,et al. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling , 2008, Oncogene.
[148] P. Hein,et al. Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium , 2000, Breast Cancer Research.
[149] D. Shelton,et al. Microarray analysis of replicative senescence , 1999, Current Biology.
[150] C Roskelley,et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[151] Masashi Narita,et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways , 2003, The EMBO journal.
[152] N. Sharpless,et al. Ink4a/Arf expression is a biomarker of aging. , 2004, The Journal of clinical investigation.
[153] Jiri Bartek,et al. Chk1 and Chk2 kinases in checkpoint control and cancer. , 2003, Cancer cell.
[154] T. Ichisaka,et al. Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.
[155] Manuel Serrano,et al. Cellular senescence: from physiology to pathology , 2014, Nature Reviews Molecular Cell Biology.
[156] Wenyi Wei,et al. Role of p21 in Apoptosis and Senescence of Human Colon Cancer Cells Treated with Camptothecin* , 2002, The Journal of Biological Chemistry.
[157] Stanley N Cohen,et al. Disparate effects of telomere attrition on gene expression during replicative senescence of human mammary epithelial cells cultured under different conditions , 2004, Oncogene.
[158] D. Peeper,et al. The essence of senescence. , 2010, Genes & development.
[159] Shuang Huang,et al. Sequential Activation of the MEK-Extracellular Signal-Regulated Kinase and MKK3/6-p38 Mitogen-Activated Protein Kinase Pathways Mediates Oncogenic ras-Induced Premature Senescence , 2002, Molecular and Cellular Biology.
[160] Thierry Soussi,et al. Shaping genetic alterations in human cancer: the p53 mutation paradigm. , 2007, Cancer cell.
[161] Senescence of activated stellate cells limits liver fibrosis. , 2008, Cell.
[162] 研宙 大内田,et al. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions , 2005 .
[163] K. Chin,et al. A Human-Like Senescence-Associated Secretory Phenotype Is Conserved in Mouse Cells Dependent on Physiological Oxygen , 2010, PloS one.